Therapeutic Approaches for Patients with Cystic Fibrosis Not Eligible for Current CFTR Modulators

Cystic fibrosis is a severe autosomal recessive disorder caused by mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene encoding the CFTR protein, a chloride channel expressed in many epithelial cells. New drugs called CFTR modulators aim at restoring the CFTR protein fun...

Descripción completa

Detalles Bibliográficos
Autores principales: Fajac, Isabelle, Sermet, Isabelle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8534516/
https://www.ncbi.nlm.nih.gov/pubmed/34685773
http://dx.doi.org/10.3390/cells10102793

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8534516/
https://www.ncbi.nlm.nih.gov/pubmed/34685773
http://dx.doi.org/10.3390/cells10102793

Ejemplares similares